Schering-Plough Corporation · Whitehouse Station, NJ United States · (NYSE: MRK)
Company Description
Phone: 908-423-1000
Fax: 908-735-1253
Rankings
- #103 in FT Global 500
- #138 in FORTUNE 500
- S&P 500
More Companies in: Kenilworth, New Jersey
More Companies in These Related Industries: Personal Safety Equipment Mfg, Toiletries Mfg, Pharmaceutical Preparation Mfg, Biologics Mfg
View Schering-Plough Corporation Locations On A US Map
This link will open in a new window
This link will open in a new window The new Merck (formerly Schering-Plough) makes medicines for a number of ailments, from stuffy noses and asthma to hypertension and arthritis. The pharmaceutical giant's top prescription drugs include asthma medication Singulair, anti-inflammatory Remicade, hypertension fighters Cozaar and Hyzaar, and cholesterol combatants Vytorin, Zetia, and Zocor. The company also makes animal health pharmaceuticals, as well as childhood and adult vaccines for such diseases as measles, mumps, hepatitis, and shingles. Its OTC drug and personal care offerings include Claritin allergy pills and Dr. Scholl's foot care products. The company completed a reverse merger with the old Merck in 2009 and took on the Merck name. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Schering-Plough Corporation Reports
No subscription, no problem.
Download presentation-ready reports for this company now.
Download presentation-ready reports for this company now.
From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.
Key Schering-Plough Corporation Financials
| Company Type | Public - NYSE: MRK Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $18,502.0 |
| 2008 Employees | 51,000 |
Schering-Plough Corporation Executives
34 executives listed for Schering-Plough Corporation's Whitehouse Station, NJ location.
| Title | Name & Bio | Contact |
| Chairman, President, and CEO | Richard Clark | |
| EVP and CFO | Peter Kellogg | |
| Chief Strategy Officer and SVP, Emerging Markets R&D, Merck Research Laboratories | Mervyn Turner |
Competition
Competitive Landscape for Schering-Plough Corporation
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Schering-Plough Corporation Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!